Merus gibt Finanzergebnisse für das erste Quartal bekannt und legt ein Update zur Geschäftsentwicklung vor

NEXT STORY
BridgeBio Pharma, Inc. Reports First Quarter 2020 Financial Results and Business Update
PREV STORY
COVID-19: Running Up the Ramp of the Remote Engagement Revolution
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

AMAG Pharmaceuticals Doubles Support of Prematurity Prevention Research

WALTHAM, Mass., Dec. 15, 2016 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced ...

author_avatar
NASDAQ Market News

Sun Biopharma, Inc. Announces Initiation of First-Line Combination Study of Sbp-101 With Gemcitabine and Nab-Paclitaxel in Patients With Pancreatic Cancer

MINNEAPOLIS, Jan. 29, 2018 (GLOBE NEWSWIRE) -- – Sun BioPharma, Inc. (OTCQB:SNBP), a clinical ...

author_avatar
NASDAQ Market News

BeiGene Reports First Quarter 2017 Financial Results

CAMBRIDGE, Mass., May 10, 2017 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE) a clinical-stage biopharmaceutical ...

author_avatar
NASDAQ Market News